Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Injectable Hormone Found to Reverse Liver Disease in HIV Patients

Researchers at the National Institutes of Health (NIH) and Massachusetts General Hospital (MGH) in Boston published research that found an injectable hormone called tesamorelin decreases liver fat and prevented liver fibrosis in HIV patients affected by non-alcoholic fatty liver disease.

Read More »

FDA approves Xeris’ glucagon pen for low blood sugar

The U.S. Food and Drug Administration approved Xeris Pharmaceuticals Inc.’s glucagon pen Gvoke, which aims to treat severely low sugar levels in diabetes patients.

Read More »

FDA Approves First Needle-Free Glucagon to Treat Severe Hypoglycemia

The FDA approved Eli Lilly’s Baqsimi (glucagon) nasal powder 3 mg to treat severe hypoglycemia in diabetics 4 years of age and older.

Read More »

Walgreens expands epinephrine shot partnership as shortage persists

Walgreens Boots Alliance Inc. expanded a partnership with Kaleo Inc. to include the company’s epinephrine auto-injectors for infants and toddlers in the drugstore chain’s pharmacies amid a national shortage of the emergency allergy shots.

Read More »

Many epinephrine self-injectors still potent long after expiration date

EpiPens and other autoinjectors filled with epinephrine to treat severe allergic reactions may still be potent enough to work many months past their labeled expiration date, according to a study that concludes patients might need expensive refills less often.

Read More »

Menopause and Estrogen Decline Could Show a Link to Alzheimer’s Disease

As pharma companies struggle with developing a treatment for Alzheimer’s disease, researchers continue to find evidence that links the dreaded form of dementia to other medical and health issues. The latest news suggests a potential link between Alzheimer’s and menopause.

Read More »

Lilly’s two-in-one diabetes product data impresses

Eli Lilly’s new two-in-one diabetes drug was successful in lowering blood sugar and reducing weight, sending the company’s shares to a record high and weighing on those of arch-rival Novo Nordisk.

Read More »

Lack of sleep tied to higher risk of diabetes in kids

Children who do not get enough sleep may be more likely to develop diabetes than kids who typically get enough shuteye, a UK study suggests.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!

Subscribe

Ad Right Bottom